Adagene Inc.
USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Adagene ranks #23,775 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 6 technology areas.
- #23,775
- of 49,997 US assignees by volume
- Top 10%
- by Innovation Score (52.2/100)
- 25.9
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R23775 · Foreign Corporation #23,775 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 11 grants
- MID-PACK #23,775/49,997
- PHOTO-FINISH Acera
- CPC-NARROW C07K · 6 areas
- INNOV-PAR 52.2/100
- CLAIMS-DENSE 25.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Acera LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Adagene’s 52.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Adagene
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Adagene · this assignee
Adagene · this assignee
52 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Adagene's Innovation Score is 52.2/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Adagene?
Each dot is one of Adagene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adagene’s own 25.9 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Adagene's grants concentrate
Adagene Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Adagene sits between Acera LLC and Adelphi Technology, Inc..
Adagene's three-year grant acceleration
Adagene Inc. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Adagene's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Acera
Acera LLC
11 patents
- Acetate Internati…
Acetate International LLC
11 patents
- Active Biotech AB
Active Biotech AB
11 patents
- Active Minerals I…
Active Minerals International, LLC
11 patents
- Adam Hall
Adam Hall GmbH
11 patents
- Adamas Pharma
Adamas Pharma, LLC
11 patents
- Adaptive 3D
Adaptive 3D Technologies, LLC
11 patents
- Adelphi Technology
Adelphi Technology, Inc.
11 patents
- Adagene ◀
Adagene Inc.
11 patents
What this shows Adagene holds 11 patents at rank #23,867, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Adagene
By rank, the assignees closest to #23,867 in granted patent volume.
- Acera LLC #23,863 · 11 patents
- Acetate International LLC #23,864 · 11 patents
- Active Biotech AB #23,865 · 11 patents
- Active Minerals International, LLC #23,866 · 11 patents
- Adam Hall GmbH #23,868 · 11 patents
- Adamas Pharma, LLC #23,869 · 11 patents
- Adaptive 3D Technologies, LLC #23,870 · 11 patents
- Adelphi Technology, Inc. #23,871 · 11 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Adagene's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Adagene's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 10% higher than 90% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 3 | 27.3% |
| 2023 | 3 | 27.3% |
| 2024 | 3 | 27.3% |
| 2025partial year | 2 | 18.2% |
Which technologies does Adagene Inc. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Adagene Inc.'s patent record in context - here's where to go next.
- Adagene Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #23,775 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Adagene Inc. against Acera LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 52.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.